CompaniesGround Zero Pharmaceuticals

Ground Zero Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

74

By Phase

PHASE4: 1PHASE2: 2

By Status

COMPLETED: 3

Clinical Trials Pipeline3 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

Today

Hover over trial bars to see details

Recent Trials

NCT04620590Collaborator

Dapagliflozin Treatment in Type 2 Diabetes

PHASE4Completed

17 participants

Started: Apr 20, 2021 · Completed: Nov 30, 2023

NCT01304316Collaborator

Dose-Escalation Safety and Pharmacokinetic Study of K305

PHASE2Completed

12 participants

Started: Sep 30, 2010 · Completed: Nov 30, 2010

NCT01302483Collaborator

Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia

PHASE2Completed

45 participants

Started: Dec 31, 2008 · Completed: Jan 31, 2009